chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna Covid-19 vaccine given to this male prior to his eighteenth birthday.  No adverse effects reported.  Today, 4/14/2021 17yo male is accompanied by his mother today for his second Moderna Covid-19 vaccination. Both were made aware that the Moderna Covid-19 vaccine?s EUA?s recommendation is for 18 year-olds and older.  Neither was aware of this recommendation and would like to receive the second.  Both denied any adverse effects from his first Covid-19 vaccination.
Day  1 Site Pain, Fatigue, Nausea, Day 2 additional symptoms Tightness is chest,Headache, Aches, Chills, Fever, Day 3 additional symptoms Lymph node pain, Day 4 additional symptoms Redness of face, Day 5 additional symtoms Swelling of face and throat, Day 6 additional symptoms Breathing Issues,Chest pain
Patient was given the meningitis vaccine and about three to four minutes later he collasped on the floor.  He fell against the wall and slid down, face was very very white and pale, so was his lips, he was unconcious until aroused by myself, which took a minuted to do so.  Patient said his stomach started to feel sick and suddenly his eye sight just went black, and then he fell.
As expected I began experiencing tiredness and nausea the day of the shot.  The following day I experienced chills, headaches and muscle aches.  As the week went on these effects lessened.  I awoke Friday morning, 4/2, with a rash/hives covering the inside of both forearms as well as my legs and ankles.  The rash is red and causes itchiness.  It disappears and reappears in other locations.  These include shoulders, biceps, back and stomach.  I have taken generic Benadryl and cortisone cream.  These help temporarily.  4/6 through 4/7 the rash has lessened.  I have not sought treatment from a medical professional.
the patient had uticaria and eczema like papules/ the patient "had a biopsy of the papules and the result was eczema"; the patient had uticaria and eczema like papules/ the patient "had a biopsy of the papules and the result was eczema"; Information has been received from a physician assistant student, referring to a 56 years old female patient. Information of pertinent medical history was unknown. The patient had none concomitant therapies or drug reactions/allergies.  In June 2019 (reported as "1 month ago"), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (1 dosage form, strength, frequency, route, lot#, therapy type and expiration date were unknown) for prophylaxis. Sterile diluent (manufacturer unknown) (strength, dose, frequency, route, lot# and expiration date were unknown) was also used.    In June 2019 (reported as "8 days later"), the patient had uticaria and eczema like papules. On 24-JUN-2019, the patient had a biopsy of the papules and the result was eczema. Treatment was given for the events. On an unspecified date in 2019, the patient was prescribed 60 mg of prednisone. The patient had sought medical attention. It was reported that the patient had not shown any improvement. The outcome of the events was not recovered. The causality assessment was not provided by the reporter.
Patient called on 9/17/19 to report possible adverse event to vaccines. She said on 09/13/19, about 9 days after receiving her first dose of 6 different vaccines, she started to get body aches and fevers. Fevers were between 102-104' F for 4 days. She also had significant joint pain. She was in bed the whole 4 days. Then the fever broke this morning , 09/17/19, and she started to get a rash. She described the rash as bumpy, red, itchy, and almost burning sensation. The rash is on her face, neck, shoulders, and chest. She thought it might be hives.
I received the injection at 11:00am and around 4:00p, I began to feel like my heart was racing. It continued until about 7p. At one point I thought I should go to the Emergency room but I began to feel better. That was about an hour and a half later but then it started again increasing but by 7p, it went away.
Has all those nerve damage in her intestine and they are not working; She has nerve and muscle damage in intestine and that is why she cannot eat; Has all those nerve damage in her intestine and they are not working; She has nerve and muscle damage in intestine and that is why she cannot eat; She hasn't been able to eat; This is a spontaneous report from a contactable consumer.  A 76-year-old female patient (reporter's mother) at the age of 76 years old received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. patient previously had first dose of BNT162B2 for covid-19 immunisation. patient had the Pfizer Covid vaccine about a month ago and about 10 days after her second vaccine, she is in hospital and she hasn't been able to eat since. She is probably going to die this week. They say that there is no blockage but she has all those nerve damage in her intestine and they are not working. reporter don't know if it is related to the vaccine or not but reporter wanted to ask if anybody else is having this problem. She has nerve and muscle damage in intestine and that is why she cannot eat. She has been fed with an IV for a month now. reporter stated it just happened 10 days after her second shot, she was fine before that. She had some other health problems and issues and other things as she is an old lady, she has had some other health things but reporter don't know if it is related or not but reporter wanted to call and see if one are getting other calls about this, about nerve damage or maybe information or what was going on. Outcome of the events was unknown.   Information on lot number/batch number was requested.
Presented to pharmacy with swelling and redness (moderate)  of the left upper arm, extending down to the elbow. Reports hives appeared 09/24, but none present 09/25. Symptoms improving per pt. report. Advised pt. to monitor for progression, and ice and/or benadryl for pain, itching, swell.
The patient received the Pfizer vaccine (2nd dose); Pt developed pancreatitis 3 days after 2nd dose of Pfizer COvid vaccine and required hospitalization due to abdominal pain. No alcohol use, no biliary stones, no hypertriglyceridemia. A mass was found on ct/mri in the pancreatic head 3.6 x 2.6 cm; repeat ct/mri 12/5/21 showed decrease in size. EUS with FNA confirmed focal mass in the pancreatic head, fine needle biopsy confirmed inflammatory accelular mucin (no malignancy). Concomitant H pylori infection found on gastric biopsies. CA 19-9 normal IgG levels and IgG4 normal. To my knowledge this is the 3rd case of pancreatitis reported after covid vaccine. Genetic testing for pancreatitis not yet completed.
I received the vaccine at 8:00am, and at approximately 7:00pm the same day, I developed a headache.  About an hour later, I developed generalized muscle aches and subjective fever/chills.  The symptoms did not interfere with my sleep, and when I woke up the next morning, the fever/chills had resolved.  The myalgia and headache resolved by approximately 11:00am the day after I received the vaccine.  I also had arm soreness from approximately 12 hours to about 72 hours after the vaccine.
Patient developed rash at the site of injection 2 days after the vacine was administered. Her doctor gave a triamcinolone to apply to the rash. She also had fever the following day.
Information has been received from a physician via a company representative referring to an unspecified patient (pharmaceutical representative of other company) of unknown age and gender. The patient's medical history and concurrent conditions were not provided. Concomitant therapies included sterile diluent (STERILE DILUENT). On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route, site of administration, lot # and expiration date unknown) for prevention of shingles. Three days later, the patient developed "shingles".  No symptoms were provided. No further patient details captured. The outcome of the event was unknown.  Causality assessment was not provided. Product quality complaint (PQC) was not involved.
Administered 0.5ml of Non-VFC flu vaccine to child under four years of age.  Mother had reported that child had had previous flu vaccines but no record available.  Contacted child's mother by telephone and she denied that child had any reactions to vaccine whatsoever.
Rash with 4 papules on R ant thigh at site of VZV vaccine admin.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 at 19:00 as DOSE NUMBER UNKNOWN, SINGLE (lot number: 903) at the age of 39 years old, administered in the left arm for COVID-19 immunization; Covid-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (batch/lot number: unknown) for COVID-19 immunization. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2023, outcome "unknown" and all described as "COVID 19 Treatment." The patient underwent the following laboratory tests and procedures: COVID-19 test (SARS-CoV-2 test): (Apr2023) Positive, notes: COVID-19 treatment. Therapeutic measures were taken as a result of Drug Ineffective, Covid-19.  The information on the batch/lot number for BNT162B2, BNT162B2 OMI BA.4-5 has been requested and will be submitted if and when received.
Patient reported feeling dizzy and chilled. Follow-up with her on 10/9/2015 and she said she still felt like she had the flu but was otherwise ok.
I contracted COVID-19 on 05/30/2022 with symptoms of fatigue, sore throat, cough, trouble sleeping, fever of 99.5, wheezing, shortness of breath, diarrhea for 2 days, and congestion. On 06/01/2022 I saw my doctor and was prescribed albuterol, benzonatate, and was instructed to take elderberry and zinc supplements. My doctor would not prescribe PAXLOVID and I was not offered the monoclonal antibodies. I am still experiencing lingering symptoms of fatigue, congestion and coughing. I do not feel recovered at this point.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 12-month-old patient of unknown gender. On 09-APR-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and a dose of VARIVAX lot number N027002 (expiration date: 28-SEP-2019) (doses, routes and anatomical locations of administration were not provided for both vaccines) for prophylaxis. This is one of multiple reports received from the same reporter. Sender's Comments: US-009507513-1807USA011661.
23 Feb 2012 vaccines were given. Patient woke up next morning and around 11:00am noticed swelling in her left clavicle area. No pain noted.
I was exposed to COVID-19 as my husband tested positive July 1, 2022. On July 5, 2022 I woke up not breathing normal but not as severe as an Asthma attack. I had a telehealth visit later that day, I was prescribed a five day course of prednisone and PAXLOVID. On July 11 and 12 I felt as if I had a relapse. Today I feel fine. During the time I was feeling ill I had body aches, felt sweaty but no fever, July 4, 2022 I had a pain in my right knee a pain I had never experienced before where I had been hit by a car years prior. I had chest congestion. As of today July 13, 2022 I do feel back to normal.
Rash on face and arms at beginning with no itching.  Eventually broke out in  five different places with itching.  Went to MDNow and was prescribed Triamcinolone Acetonide which cleared up my face but has not helped with the itching. I have used Lanacane to alleviate the itching.
Period was delayed; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on 23Feb2021 (at the age of 28-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on 16Mar2021 (at the age of 28-years-old) as single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On an unknown date in Feb2021, the patient's period was delayed with 74 days between cycles (20Feb2021 to 05May2021). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event period was delayed was resolved on 05May2021.  No follow-up attempts are needed. No further information is expected.
This spontaneous case reported by an other healthcare professional, describes the occurrence of pain (body ache), injection site pain (sore at injection site), fatigue and pyrexia (fever of 100ºF) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# unknown) for COVID-19 immunization. No medical history reported. On Apr 29, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 30, 2021, patient experienced pain (body ache), injection site pain (sore at injection site), fatigue and pyrexia (fever of 100ºF). Patient treated with Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, pain (body ache), injection site pain (sore at injection site), fatigue and pyrexia (fever of 100ºF) outcome: unknown. The reporter did not provide any causality assessments or concomitant medications. Action taken with mRNA-1273 in response to the event: not applicable.
Walked to clinic by principal. After receiving immunizations student began to cough immediately, eyes puffy and red. Student complained of chest tightness. BENADRYL 25mg oral liquid given at 1154 AM for itching.
Fever x2 days starting 2/28, now resolved. Rash appeared 3/2, initially on face & spread to torso. Diagnosed with otitis media & URI 2/28/13.
I started feeling feverish and achy the same afternoon after I received the shot. That night I had night sweats and some fever. The next morning I still felt achy and feverish but my lower swole up.  The rest of the day I was tired and feverish and achy. The next morning my whole face swole up, under my eyes, my cheeks, my upper lip, the area between my eyes (globela). Those areas where exactly where I had had Hyaluronic Acid injections in the past. I haven't had any Hyaluronic Acid injections in the last year and a half.  I used ice and arnica to reduce the swelling. I took Benadryl and Zyrtec but they didn't seem to help. The swelling went down gradually and was gone two days later.
Patient reported receipt of annual flu vaccine 10/30/2015 with AFLURIA Lot# U56506, MFT CSL to his right deltoid during flu-fair. He advised leaving immediately after being vaccinated and began to cough. This lasted for a few moments and resolved once back in area about 1 mile away. Approximately <30 min later he felt a numbness/fullness to right nostril as if stuffy. Over next 2 hours this numbness worsened to right side of face along jaw and tongue (as if went to dentist). He denied any difficulty speaking, chewing, swallowing and no numbness to neck/eye/ear. He denied difficulty moving jaw/facial/neck muscles. This sensation and nasal fullness resolved by 9pm when he went to bed. He awoke the next morning with a dull 1/10 headache over frontal sinuses that persisted all day resolving later that evening. He again denied any fevers, chills, n/v, visual disturbances, tinnitus, weakness, rash, neck pain or any systemic like symptoms. HA was not like past migraine headaches - not as severe and different location. He advised he ate 2 homemade breakfast sandwiches with ginger tea which he had had before and since without reaction. He denied any new detergents, deodorants, food groups, trauma, odor exposure, or recent exercise prior to/after vaccination. He reported having mild pollen allergy but was never tested for.
Approximately 1 hour after the vaccination, Patient reported feeling a sudden "pop" in his head.  That was followed by loss of balance, weakness, and inability to walk.  He collapsed and either passed out or slept for 2-3 hours.  Upon awakening he still felt weak and unbalanced.  He also had bitten his tongue and lip while unconscious. He slowly recovered over a period of 3-4 days after the vaccination.  He has never before had a stroke or a seizure. No one was with him to observe any of his symptoms.
Sudden unilateral sensorineural hearing loss, mild. Treated with oral prednisone. Symptoms fully resolved.
patient is a 58 y old female with h/o HTN , dyslipidemia , hypothyroidism , Dm2, CKD 3 , chronic liver disease secondary to NASH among others who currently is established with hospice and is a DNR refers that for the last couple of days has been bedbound and weak . Refers that is unable to get out of bed . Also describes subjective fevers and worsening sob . Refers that husband has similiar symptoms suggestive of covid 19 . Refers having 2 doses of covid 19 vaccine - Pfizer back in April 2021 . Due to worsening weakness came to er . seems that initially was requiring 02 non rebreather with pulse ox 89 % . At time of exam patient is not febrile , not having cough and is currently on 6 liters 02 per nc . Patient is a poor historian and doesnt know what meds she takes though says that took water pills this am . Refers that regarding code status wants to have some things done if able to be kept alive but doesnt want to prolong her life either. On admission her cbc reveals no leukocytosis . Has lymphopenia . Patient has evidence of hyponatremia and AKI with creatinine 1.7 probably reflective of use of bumex and spironolactone at home . CXR reveals b/l infiltrates consistent with possible pneumonia  . ER has requested admission for eval and treatment of covid 19 .  Patient at this time is not tachypneic and is not coughing actively . Is requiring 02 and is at risk for progression and worsening disease.
Case number PHEH2015US020375 is an initial spontaneous report received from a pharmacist on 12 Oct 2015. This report refers to a 66 year old male patient. Past medical history and concomitant medications were not reported. He was vaccinated with FLUVIRIN (batch number: 15751P) pre-filled syringe (PFS) intramuscularly on an unknown date. It was reported that on 05 Oct 2015 the patient experienced loss of balance, fever at 103 degree Fahrenheit, dizziness, stiffness and he could not move. The events outcome was unknown. The seriousness and causality of the events not reported.
Within minutes my arms had huge red blotches. I took a Benadryl from my purse and alerted a nurse. She talked to me and then my throat went tight. They had to administer an epi-pen. My throat did not feel better so I was transported by EMS to the hospital and was treated with IV Benadryl, steroids and Pepcid. I was prescribed Pepcid and Medrol 6 day dose pack to take home to prevent a delayed reaction.
DTAP to RAT given became red, swollen, hard and warm to touch. Redness 14x15cm.
Within 12 hours of receiving the vaccine pt had, malaise, h/a, n/v, fever (102.0), sore throat and cough.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 31-MAY-2013, the patient was vaccinated with a dose of GARDASIL, (lot # H021608, expiry date 13-AUG-2015), which was exposed to 31 Fahrenheit for 1 hour. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Female patient who was immunized with her second dose of MODERNA with batch 036C21A. After being immunized, she is sent to the observation area where she states that she feels bad, at the time she was accompanied by her minor child. They proceeded to call the paramedics who were in the ambulance when they took the vital signs, their pressure was 180/100, 104 pulse, saturation of 95. They proceed to orient the patient who initially refuses to attend the hospital. The "head nurse" oriented the patient about the importance of treating his high blood pressure, who after hearing the recommendations decided to go to the hospital. At 11:50 am the patient is transported to the ambulance to be taken to the hospital.
The patient is a 42-year-old female with a history of extensive allergies who presents for a possible allergic reaction status-post receiving her 1st dose of the Pfizer COVID vaccine 30 minutes ago. She notes symptoms of tongue numbness and an itchy throat. She reports a history of anaphylaxis secondary to a bee sting and contrast dye, but denies reactions to prior immunizations. The patient also has a history of Factor V Leiden blood disorder, but denies taking daily medications. She denies shortness of breath, nausea, vomiting, diarrhea, abdominal pain, chest pain or rash.
This infant was immunized 08/08/01. She had a rash on her face, body, extreme started 08/18/01. Blisters on her buttock on 08/17/01, and the next day head to toe pruritic rash.
Tightness and pressure in my chest/with pain... was admitted for observation ... found fluid around my heart... given echo...and medication given and several trips to dr's offices....additional meds added for high blood pressure
Mom reported that patient became very fussy with a shrill cry after receiving vaccines. He calmed after he was given TYLENOL, but was abnormally fussy for 24-48 hours. He had one episode of blood in his stool.